Eplerenone in Patients Undergoing REnal Transplant (EPURE TRANSPLANT)
NCT02490904
·
clinicaltrials.gov ↗
PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
132
Enrollment
OTHER
Sponsor class
Conditions
End-stage Renal Disease
Interventions
DRUG:
Eplerenone
DRUG:
Placebo
Sponsor
Central Hospital, Nancy, France